ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-09-14–present
Board Member
Alkermes plc. (ALKS)Equibles does not estimate personal net worth.
Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.
Get ALKS alertsAnne C. Whitaker is recorded as Board Member at Alkermes plc. (ALKS) since September 14, 2026. Alkermes plc. reported in an 8-K filed September 16, 2026 that Anne C. Whitaker was appointed Director, effective September 14, 2026. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
“On September 14, 2026, the board of directors (the "Board") of Alkermes plc (the "Company") increased the size of the Board from ten (10) to eleven (11) directors and appointed Anne C. Whitaker to the Board, effective immediately, with an initial term expiring at the Company's 2027 annual general meeting of shareholders.”
2026-09-14–present
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-09-14–present